Detalhe da pesquisa
1.
Trial of Intravenous Immune Globulin in Dermatomyositis.
N Engl J Med
; 387(14): 1264-1278, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198179
2.
Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy.
Brain
; 145(3): 887-896, 2022 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35038723
3.
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.
Arthritis Res Ther
; 26(1): 27, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38233885
4.
Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study.
Drug Saf
; 46(9): 835-845, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37378806
5.
Treatment of children with primary immunodeficiencies with a subcutaneous immunoglobulin 16.5% (cutaquig® [octanorm]).
Immunotherapy
; 13(10): 813-824, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33955240